Unbiased Analysis of Today's Healthcare Issues

Who gets hurt when Americans buy drugs in Canada?

Written By: Jason Shafrin - Jan• 16•13

A few years ago, changing federal laws to lower drug prices was a key political issue. Some proposed allowing Medicare to negotiate lower prices from drug manufacturers and others recommended allowing U.S. citizens to import drugs from lower-priced developed countries such as Canada. These policies would certainly reduce drug prices, however, lower prices could also stifle drug innovation. Thus, the welfare effect on U.S. citizens is uncertain.

The welfare effect on citizens of other countries, however, has been largely ignored. It turns out, Candadians and other countries that currently have low-cost drugs could be the big losers if the U.S. begins negotiating drugs prices based on the prices paid in other countries. A paper by Danzon and Epstein explains why:

We…find that launch timing and prices of innovative drugs are influenced by prices of established products. Thus, if price regulation reduces drug prices, it contributes to launch delay in the home country. New drug launch hazards and launch prices in low-price countries are also affected by referencing by other, high-price countries, especially within the EU, as expected if manufacturers delay launch in low-price markets to avoid undermining higher prices in other countries. Thus, referencing policies adopted in high-price countries can impose welfare loss on low-price countries.

Since most U.S. voters likely do not care about externalities imposed on other countries, however, this argument (although potentially very important for these countries) is unlikely to affect the political debate. Seniors’ out-of-pocket drug costs and pharmceutical lobbyists are much more likely to have an effect on the debate.

Source:

You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

2 Comments

  1. It will be interesting to see how these changes develop with ObamaCare. When did life get so complicated?

  2. E.T. Bass says:

    Jason, another engaging post.

    IMHO, the issue that the T.R. Reids of the world cannot cognitate — the Glaxos of the world have *global* pricing structures.

    Thus, the real question that the Michael Moores of the world do not have the IQs to grasp: has the USA been subsidizing pharm development?

    Of course. Any fool can see that.

    But it does not fit the “Bush’s fault” mind-set, so it goes in the toilet.

    OweBama-care is destroying global health care.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>